GG
PFE icon

Gleason Group’s Pfizer PFE Stock Holding History

Gleason Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-197
Closed -$5.53K – 448
2026
Q1 		$5.53K Buy
+197
New +$5.25K ﹤0.01% 196
2025
Q3 		– Sell
-1,220
Closed -$29.6K – 198
2025
Q2 		$29.6K Buy
1,220
+21
+2% +$490 ﹤0.01% 134
2025
Q1 		$30.4K Buy
1,199
+19
+2% +$497 0.01% 129
2024
Q4 		$31.3K Buy
1,180
+19
+2% +$515 0.01% 131
2024
Q3 		$33.6K Sell
1,161
-522
-31% -$15.2K 0.01% 130
2024
Q2 		$47.1K Buy
1,683
+140
+9% +$3.85K 0.01% 125
2024
Q1 		$42.8K Buy
1,543
+23
+2% +$638 0.01% 120
2023
Q4 		$43.8K Sell
1,520
-793
-34% -$24K 0.01% 121
2023
Q3 		$76.7K Buy
2,313
+26
+1% +$919 0.02% 98
2023
Q2 		$83.9K Sell
2,287
-102
-4% -$3.97K 0.02% 94
2023
Q1 		$97.5K Buy
2,389
+1,080
+83% +$46.6K 0.03% 89
2022
Q4 		$67.1K Sell
1,309
-518
-28% -$24.8K 0.02% 100
2022
Q3 		$80K Buy
1,827
+544
+42% +$26.4K 0.03% 90
2022
Q2 		$67K Sell
1,283
-51
-4% -$2.6K 0.02% 99
2022
Q1 		$69K Buy
1,334
+71
+6% +$3.68K 0.02% 104
2021
Q4 		$75K Buy
1,263
+9
+0.7% +$446 0.02% 93
2021
Q3 		$54K Buy
1,254
+11
+0.9% +$487 0.02% 107
2021
Q2 		$49K Buy
1,243
+12
+1% +$467 0.02% 108
2021
Q1 		$45K Buy
1,231
+477
+63% +$16.9K 0.02% 107
2020
Q4 		$28K Sell
754
-1,589
-68% -$58.3K 0.01% 115
2020
Q3 		$82K Buy
2,343
+23
+1% +$806 0.05% 74
2020
Q2 		$72K Buy
2,320
+24
+1% +$815 0.04% 75
2020
Q1 		$71K Buy
2,296
+25
+1% +$852 0.06% 69
2019
Q4 		$84K Buy
+2,271
New +$80.9K 0.05% 77

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gleason Group's PFE Position: Q2 2026 in Review

Gleason Group sold out of Pfizer (PFE) in Q2 2026, closing a stake of 197 shares — an estimated $5.53K sold.

Gleason Group first reported a position in PFE in Q4 2019 and held it in 24 quarters. The position peaked at $97.5K in Q1 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Gleason Group reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Gleason Group sold 197 Pfizer shares in Q2 2026, an estimated $5.53K.
  • Gleason Group first reported a position in Pfizer in Q4 2019 and held it in 24 quarters.
  • Gleason Group's Pfizer position peaked at $97.5K in Q1 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.